 This is a Phase 2a, randomized, double-blind, placebo-controlled, parallel-arm study to evaluate the efficacy and safety of 3 subcutaneous SC treatment regimens of CAT-354 in adult subjects with uncontrolled, moderate-to-severe, persistent asthma. 